Effects of purinergic stimulation, CFTR and osmotic stress on amiloride-sensitive Na+ transport in epithelia and Xenopus oocytes

J Membr Biol. 2003 Mar 15;192(2):101-10. doi: 10.1007/s00232-002-1067-8.

Abstract

Both stimulation of purinergic receptors by ATP and activation of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibit amiloride-sensitive Na+ transport and activate Cl- secretion. These changes in ion transport may well affect cell volume. We therefore examined whether cell shrinkage or cell swelling do affect amiloride-sensitive Na+ transport in epithelial tissues or Xenopus oocytes and whether osmotic stress interferes with regulation of Na+ transport by ATP or CFTR. Stimulation of purinergic receptors by ATP/UTP or activation of CFTR by IBMX and forskolin inhibited amiloride-sensitive transport in mouse trachea and colon, respectively, by a mechanism that was Cl- dependent. When exposed to a hypertonic but not hypotonic bath solution, amiloride-sensitive Na+ transport was inhibited in mouse trachea and colon, independent of the extracellular Cl- concentration. Both inhibition of Na+ transport by hypertonic bath solution and ATP were additive. When coexpressed in Xenopus oocytes, activation of CFTR by IBMX and forskolin inhibited the epithelial Na+ channel (ENaC) in a Cl- dependent fashion. However, both hypertonic and hypotonic bath solutions showed only minor effects on amiloride-sensitive conductance, independent of the bath Cl- concentration. Moreover, CFTR-induced inhibition of ENaC could be detected in oocytes even after exposure to hypertonic or hypotonic bath solutions. We conclude that amiloride-sensitive Na+ absorption in mouse airways and colon is inhibited by cell shrinkage by a mechanism that does not interfere with purinergic and CFTR-mediated inhibition of ENaC.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Amiloride / pharmacology
  • Animals
  • Colforsin / metabolism
  • Cystic Fibrosis Transmembrane Conductance Regulator / drug effects
  • Cystic Fibrosis Transmembrane Conductance Regulator / physiology*
  • Female
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / physiology*
  • Ion Channel Gating / physiology
  • Ion Transport / drug effects
  • Ion Transport / physiology
  • Mannitol
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mice
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Oocytes / physiology*
  • Osmotic Pressure / drug effects
  • Purines
  • Receptors, Purinergic / drug effects
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / metabolism
  • Respiratory Mucosa / physiology*
  • Sodium / pharmacokinetics*
  • Sodium Chloride / pharmacology
  • Trachea / drug effects
  • Trachea / metabolism
  • Trachea / physiology
  • Uridine Triphosphate / pharmacology
  • Xenopus laevis

Substances

  • Purines
  • Receptors, Purinergic
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Colforsin
  • Mannitol
  • Sodium Chloride
  • Amiloride
  • Sodium
  • 1-Methyl-3-isobutylxanthine
  • Uridine Triphosphate
  • Indomethacin